Hilton Head Island, South Carolina, United States
Experienced executive with proven track record of creating significant shareholder value in the pharmaceutical, life sciences, healthcare and financial services industries. Demonstrated strength in growing businesses through innovative strategies that find, win and keep profitable customers. Expertise in leading global consulting teams to generate value from data and analytics. Specialties: Marketing Strategy (segmentation, targeting, positioning), New Product Launch, Sales Force Strategy, Sales Operations, Customer Valuation, Analytics. Highlights: supported launches of >$8 Bn new pharmaceutical brands; transformed sales organizations ranging in size from 8 to 8,000 P.S. - I literally do not purchase ANYTHING (professionally), so please don't waste any of your precious time soliciting me for goods & services!
Axtria is a Cloud software and Data Analytics company that helps global life sciences companies run commercial operations. Axtria's cloud-based software platforms are #1 in the life-sciences industry in enabling clients to leverage data, use predictive analytics-AI to do business planning, and run commercial operations at scale. 22 of the top 30 global life sciences companies use Axtria platforms in their commercial operations across 100+ countries. Our platforms have enabled clients to accelerate their digital transformation journey, replacing expensive and outdated legacy consulting/services companies. Axtria is constantly looking for world-class, passionate, life sciences consulting and client service talent. We attracted top talent and are a multi-country, multi-year, Great-Places-To-Work recognized culture. $150MM growth investment by Bain Capital Tech Opportunities validates Axtria's strategy, team, and platforms with unicorn status.
marketRx was a consulting and technology company that delivered revenue growth and cost saving solutions to global pharmaceutical/biotech clients. Venture-backed by Sequoia Capital, marketRx grew to 550 professionals, earned spot #195 on Inc.500 and Entrepreneur Magazine’s “Hot 100”. In 2007, the firm was acquired by Cognizant Technologies for over $135 million (> 15x shareholder return). Trusted adviser & innovative problem solver for sales & marketing executives. Worked with 11 of top 15 global pharmaceutical firms. Managed 8-figure P&L and matrixed team of over 60 professionals Led major sales organization transformation initiatives: - Implemented new selling model with top-10 pharma to create more nimble, customer focused organization. Over 8,000 sales personnel redeployed to new positions and territories. - Restructured sales team of 2,700, including a 20% RIF, in 100 days. - Top-5 pharma: deployed iAlign platform to over 7,500 reps; accelerated operational cycle times and reduced annual vendor costs $2 million Launched marketRx’s sales force deployment and territory alignment practice; expanded business 10x in three years. Developed innovative SaaS platforms: iAlign, People Placement, Launchpad. http://www.livemint.com/2007/10/20000406/Cognizant-acquires-marketRx-fo.html
A $400 million provider of health information services to pharmacy, hospital, physician, pharmaceutical and payer businesses. NDCHealth clients included over 100 pharmaceutical manufacturers, 90% of the nation's pharmacies, 20% of hospitals, 100,000 physicians, and 1,000 payers. Managed relationship for NDCHealth’s largest client, a major pharmaceutical firm. Led team of business development, account management, and consulting professionals. Responsible for eight-figure revenue across multiple lines of business, including informatics and consulting.
Launched a new department to support Assurant’s direct marketing operations (15,000 campaign executions, 521 clients, .65 billion consumer contacts over two years) through consumer analysis, research and predictive modeling. Managed team of statisticians, analysts, and project managers.
Strategy consulting in healthcare and financial services industries. Recruited away by client (Assurant/Fortis) to implement recommended strategy concurrent with a major merger.